Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bigonnesse, F.
Right arrow Articles by Akoum, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bigonnesse, F.
Right arrow Articles by Akoum, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 7, No. 4, 333-339, April 2001
© 2001 European Society of Human Reproduction and Embryology

Interleukin-1 receptor accessory protein is constitutively expressed in human endometrium throughout the menstrual cycle

François Bigonnesse1, Michel Marois2, Rodolphe Maheux1 and Ali Akoum1,3

1 Unité d'Endocrinologie de la Reproduction, Centre de Recherche, 2 Département de pathologie, Hôpital Saint-François d'Assise, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada

Interleukin-1 (IL-1) is one of the principal cytokines that participate in endocrine and local regulation of many endometrial and reproductive functions. The cellular response to IL-1 principally implicates receptor type 1 (IL-1R tI) and, according to recent data, an accessory protein (IL-1R-AcP) that seems to play an essential function in signal transduction. In the present study, we examined the expression of IL-1R-AcP in the endometrium of 39 normal fertile women throughout the menstrual cycle. As studied by immunohistochemistry, IL-1R-AcP was detected across endometrial tissue, but more noticeably in the glands and luminal epithelium. The intensity of IL-1R-AcP immunostaining was consistently high throughout the menstrual cycle, and this was confirmed by Western blot analysis of the protein and corroborated by reverse transcription-polymerase chain reaction analysis of the mRNA. To our knowledge, this is the first report showing that IL-1R-AcP is expressed in endometrial tissue, and without any noticeable variation throughout the menstrual cycle. This suggests that the accessory protein, whose co-expression is critical for IL-1R tI-mediated cell activation, is, in contrast to the functional receptor, constitutively expressed and not subject to similar cycle-dependent regulation.

endometrium/interleukin-1/IL-1R-AcP/menstrual cycle

3 To whom correspondence should be addressed at: Unité d'Endocrinologie de la Reproduction, Centre de Recherche, Hôpital Saint-François d'Assise, Centre Hospitalier Universitaire de Québec, 10, rue de l'Espinay, Local D0-711, Québec, Québec, Canada, G1L 3L5. E-mail: ali.akoum{at}crsfa.ulaval.ca


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
C. Bellehumeur, T. Collette, R. Maheux, J. Mailloux, M. Villeneuve, and A. Akoum
Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis
Hum. Reprod., May 1, 2005; 20(5): 1177 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. W. Ross, J. R. Malayer, J. W. Ritchey, and R. D. Geisert
Characterization of the Interleukin-1{beta} System During Porcine Trophoblastic Elongation and Early Placental Attachment
Biol Reprod, October 1, 2003; 69(4): 1251 - 1259.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Kharfi, A. Boucher, and A. Akoum
Abnormal Interleukin-1 Receptor Type II Gene Expression in the Endometrium of Women with Endometriosis
Biol Reprod, February 1, 2002; 66(2): 401 - 406.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.